Zura Bio Ltd Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zura Bio Ltd quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2022 to Q3 2024.
  • Zura Bio Ltd Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.65M, a 236% increase year-over-year.
  • Zura Bio Ltd Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $16.4M.
  • Zura Bio Ltd annual Share-based Payment Arrangement, Expense for 2023 was $9.66M, a 2791% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $16.4M $8.65M +$6.07M +236% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $10.3M $2.93M +$607K +26.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $9.7M $2.41M +$43K +1.82% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.66M $2.39M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $2.58M +$2.57M +21375% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.32M +$2.01M +650% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.37M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $12K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $309K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.